22 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
15
Discovery of high affinity inhibitors of Leishmania donovani N-myristoyltransferase.

Imperial College
20
Discovery of pyridyl-based inhibitors of Plasmodium falciparum N-myristoyltransferase.

Imperial College
48
Lead optimization of a pyrazole sulfonamide series of Trypanosoma brucei N-myristoyltransferase inhibitors: identification and evaluation of CNS penetrant compounds as potential treatments for stage 2 human African trypanosomiasis.

University of Dundee
6
Structure-based design of potent and selective Leishmania N-myristoyltransferase inhibitors.

Imperial College
7
Discovery of novel and ligand-efficient inhibitors of Plasmodium falciparum and Plasmodium vivax N-myristoyltransferase.

Imperial College
27
Design and synthesis of inhibitors of Plasmodium falciparum N-myristoyltransferase, a promising target for antimalarial drug discovery.

Imperial College
16
Discovery of Plasmodium vivax N-myristoyltransferase inhibitors: screening, synthesis, and structural characterization of their binding mode.

Imperial College
24
Discovery of a novel class of orally active trypanocidal N-myristoyltransferase inhibitors.

University of Dundee
14
Derivatives of aryl amines containing the cytotoxic 1,4-dioxo-2-butenyl pharmacophore.

Acadia University
6
A chiral recognition element with an unusual size constraint affects the potency and selectivity for peptidomimetic inhibitors of
Candida albicans myristoyl-CoA:protein
N-myristoyltransferase

TBA
5
Structure guided modification of 2-chloro-5-(ethyl-phenyl-sulfamoyl)-N-[2-(2-oxo-pyrrolidin-1-yl)-phenyl]-benzamide to afford selective inhibitors of Cryptosporidium parvum N-myristoyltransferase.

University of Washington
3
NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family.

Johann Wolfgang Goethe University
21
Exploring N-myristoyltransferase as a promising drug target against parasitic neglected tropical diseases.

State University of Paraiba
56
Fragment Linking Strategies for Structure-Based Drug Design.

University of Lyon
38
Novel Thienopyrimidine Inhibitors of

Imperial College London
12
Fragment-to-Lead Medicinal Chemistry Publications in 2018.

Frontier Medicines
11
How To Design Selective Ligands for Highly Conserved Binding Sites: A Case Study Using

Johannes Gutenberg-Universit£T Mainz
50
A Molecular Hybridization Approach for the Design of Potent, Highly Selective, and Brain-Penetrant N-Myristoyltransferase Inhibitors.

University of Dundee
38
Design and Synthesis of Brain Penetrant Trypanocidal N-Myristoyltransferase Inhibitors.

University of Dundee
157
PYRIMIDINE COMPOUND AS WEE-1 INHIBITOR

Wigen Biomedicine Technology (Shanghai)
8
Peptidomimetic 2-cyanopyrrolidines as potent selective cathepsin L inhibitors.

The M. S. University of Baroda
26
Structural optimization of thiol-based inhibitors of glutamate carboxypeptidase II by modification of the P1' side chain.

Mgi Pharma